Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardio-Oncology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1593824

This article is part of the Research TopicCancer and Cardiovascular Diseases: Common Mechanisms and Strategies of PreventionView all articles

L-shaped Association of Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Cancer Survivors: A Population-based Cohort Study

Provisionally accepted
Bowen  HouBowen Hou1Yali  HuYali Hu1Hairong  WangHairong Wang1Huang  ZhangHuang Zhang2Xingyu  GaoXingyu Gao1Ying  CuiYing Cui1Yilin  ZhaoYilin Zhao1Jing  XieJing Xie1Xiaomei  YuXiaomei Yu1Lang  WangLang Wang1Hong  JiangHong Jiang1Lihua  ZhuLihua Zhu1*
  • 1Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China
  • 2Zhongnan Hospital, Wuhan University, Wuhan, Hubei Province, China

The final, formatted version of the article will be published soon.

Objectives: To evaluate the association between LDL-C levels and all-cause, cardiovascular, and cancer mortality in cancer survivors, and to identify the LDL-C level associated with the lowest mortality risk, using data from NHANES 1999–2018. Study design: Population-based cohort study Methods: We analyzed 1,958 U.S. cancer survivors from the National Health and Nutrition Examination Survey (NHANES) 1999-2018. We used Cox and Fine-Gray model to compare mortality risks across LDL-C quartiles, combined with restricted cubic spline analysis to assess nonlinear relationships, and piecewise linear regression to identify LDL-C inflection points. Results: During a median follow-up of 7.3 years (681 deaths were recorded), we observed a nonlinear association between LDL-C levels and all-cause/cardiovascular mortality, wherein low levels of LDL-C were associated with an increased mortality risk. The identified optimal LDL-C thresholds were 119 mg/dL for all-cause mortality and 124 mg/dL for cardiovascular mortality. Age and CVD history influenced the association, with a negative linear relationship between LDL-C and all-cause mortality observed in individuals aged under 65 years and those in the primary CVD prevention. Conclusions: Cancer survivors with low LDL-C levels were correlated with elevated all-cause and CVD mortality risks, particularly in younger patients and those without prior CVD.

Keywords: cancer survivors, LDL-C levels, Population study, Mortality, NHANES

Received: 14 Mar 2025; Accepted: 30 Aug 2025.

Copyright: © 2025 Hou, Hu, Wang, Zhang, Gao, Cui, Zhao, Xie, Yu, Wang, Jiang and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lihua Zhu, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.